Expanding the relevance of anti-Ki/SL beyond systemic lupus erythematosus to systemic sclerosis and dermatomyositis in in-house enzyme-linked immunosorbent assay analyses
Anti-Ki/SL antibodies are most commonly found in patients with systemic lupus erythematosus, they show broader relevance to systemic sclerosis and dermatomyositis. We developed an in-house enzyme-linked immunosorbent assay for anti-Ki/SL antibodies that are not included in the line blot assay.
Authors
- Norika Akashi (ORCID: https://orcid.org/0000-0001-6652-8893)
- Mariko Ogawa‐Momohara (ORCID: https://orcid.org/0000-0003-1595-1522)
- Yuta Yamashita (ORCID: https://orcid.org/0000-0002-7604-3248)
- Haruka Koizumi (ORCID: https://orcid.org/0000-0002-3332-3979)
- Satoshi Kamiya (ORCID: https://orcid.org/0000-0001-6233-6376)
- Takuya Takeichi (ORCID: https://orcid.org/0000-0001-5958-2875)
- Yoshinao Muro (ORCID: https://orcid.org/0000-0003-2329-8375)
- Masashi Akiyama (ORCID: https://orcid.org/0000-0001-5863-9315)
- E Noda
Institutions
- Nagoya University Hospital (JP)
- Nagoya University (JP)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1093/ced/llaf166
- Citations
- 1
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 1.35